Nonetheless, our data indicate that IL-1 plays a key role in Th17 cell development in human autoimmune disease, and support the notion that IL-1 signaling blockade is a potential strategy to treat patients with these conditions. The gene discussed is IL1A; the disease is autoimmune disease.